Plain English Breakdown
The official source material does not provide additional details about the exact conditions under which prior authorization is prohibited beyond the specified cost limit and opioid exclusion.
Insurance Law Change for Generic Medications
This law stops insurance companies from requiring special approval before paying for certain generic medications prescribed by board-certified doctors in Louisiana.
What This Bill Does
- Adds rules to stop health insurance companies from needing prior authorization for some generic drugs that are not opioids, if the prescription is issued by a board-certified physician or authorized provider whose specialty certification includes the medical indication for which the drug is prescribed and the wholesale acquisition cost is no more than $250 per prescription.
- Defines 'board-certified physician' as a doctor licensed to practice medicine in Louisiana who is certified by a recognized medical board.
- Explains what a 'generic medication' is, meaning it's chemically equivalent to a brand-name drug and approved by the FDA as interchangeable.
Who It Names or Affects
- People with health insurance in Louisiana who need certain generic medications that are not opioids.
- Insurance companies that offer health plans in Louisiana.
Terms To Know
- Board-certified physician
- A doctor licensed to practice medicine in Louisiana and certified by a recognized medical board.
- Generic medication
- A drug that is chemically equivalent to a brand-name drug and approved by the FDA as interchangeable.
Limits and Unknowns
- The law only applies to generic medications that are not opioids.
- Insurance companies must follow these rules starting January 1, 2027 for new policies and by January 1, 2028 for existing ones.